3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
5
Unknown
3
Active not recruiting
3
Withdrawn
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
542
Triple Negative Breast Neoplasms
86
Neoplasms
18
Colorectal Neoplasms
18
Lung Neoplasms
16
Neoplasm Metastasis
15
Advanced Breast Cancer
15
Prostatic Neoplasms
14
Carcinoma, Non-Small-Cell Lung
14
Motor Activity
12
Breast Cancer Lymphedema
12
HER2-positive Breast Cancer
11
Uterine Cervical Neoplasms
10
Stomach Neoplasms
10
Ovarian Neoplasms
10
Endometrial Neoplasms
10
Carcinoma, Intraductal, Noninfiltrating
10
Anxiety Disorders
10
Depression
8
Brain Neoplasms
7
Squamous Cell Carcinoma of Head and Neck
6
Pain, Postoperative
6
Pain
6
Melanoma
6
Lymphedema
6
Head and Neck Neoplasms
6
Colonic Neoplasms
6
Cardiotoxicity
6
Pancreatic Neoplasms
5
Liver Neoplasms
5
Interventions
exemestane
1
Tamoxifen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Carcinoma, Ductal
×
Breast
×
Clear all
NCT07499999
2026-03-30
BabyTEARS
Dana-Farber Cancer Institute
Phase 2
Not yet recruiting
140 enrolled